يعرض 21,101 - 21,120 نتائج من 36,983 نتيجة بحث عن '(( significant ((clinical disease) OR (linear decrease)) ) OR ( significant decrease decrease ))', وقت الاستعلام: 0.62s تنقيح النتائج
  1. 21101

    Baseline Risk and Longitudinal Changes in KidneyintelX.dkd and Its Association with Kidney Outcomes in the CANVAS and CREDENCE Trials حسب Erik Moedt (22379907)

    منشور في 2025
    "…<p dir="ltr">Objective</p><p dir="ltr">We aimed to evaluate the prognostic and clinical utility of kidneyintelX.dkd, a biomarker-based risk score, in patients with type 2 diabetes and a broad range of chronic kidney disease (CKD), by assessing its association with kidney outcomes at baseline and longitudinally, comparing it to the established KDIGO risk classification, and examining its responsiveness to canagliflozin. …"
  2. 21102

    The association of the age at type 2 diabetes onset with diabetes progression حسب Seyedeh Forough Sajjadi (22463276)

    منشور في 2025
    "…<p dir="ltr">Objective</p><p dir="ltr">To examine whether age at type 2 diabetes onset impacts disease progression, assessed by changes in glycaemic control and clinical biomarkers during follow-up.…"
  3. 21103
  4. 21104
  5. 21105
  6. 21106
  7. 21107
  8. 21108
  9. 21109
  10. 21110

    Data Sheet 1_Multivitamin supplementation as a potential adjunctive therapy in post-cardiac arrest: insights from a multicenter retrospective analysis of MIMIC-IV and eICU-CRD.docx حسب Jiahao Shen (7877492)

    منشور في 2025
    "…After PSM and IPTW adjustment, multivitamin use remained significantly associated with lower mortality in both cohorts. …"
  11. 21111
  12. 21112
  13. 21113
  14. 21114
  15. 21115
  16. 21116
  17. 21117

    Table 1_Global, regional, and national burden of atrial fibrillation/flutter attributable to metabolic, behavioral, and environmental risk factors, 1990–2021: a longitudinal observ... حسب Zhen Wei (203204)

    منشور في 2025
    "…Smoking showed the greatest decrease, with AAPCs of ASMR and ASDR at −0.66 (95% CI: −0.68 to −0.65) and −0.72 (95% CI: −0.72 to −0.71), most significantly in women aged 30–34. …"
  18. 21118
  19. 21119

    Table 1_A compilation of 13 patients with metastatic colorectal cancer and concomitant BRAF and RAS family mutations.docx حسب Jigisha Srivastav (22116340)

    منشور في 2025
    "…Introduction<p>Metastatic colorectal cancer (mCRC) exhibits significant heterogeneity in molecular profiles, influencing treatment response and patient outcomes. …"
  20. 21120

    Table 2_A compilation of 13 patients with metastatic colorectal cancer and concomitant BRAF and RAS family mutations.docx حسب Jigisha Srivastav (22116340)

    منشور في 2025
    "…Introduction<p>Metastatic colorectal cancer (mCRC) exhibits significant heterogeneity in molecular profiles, influencing treatment response and patient outcomes. …"